The pace of clinical innovation is accelerating—new biosimilars, investment in precision medicine, and accelerated approvals make for a rapidly evolving landscape of medical treatment options. Meanwhile, emerging real-world data sources and advanced analytics capabilities create opportunities to generate new, more compelling evidence of value. In response, payers are adapting their processes for measuring and assessing the value of drugs and devices.

This research identifies the key elements that shape payers’ definitions of value, outlines how payers are adapting their evaluation processes, and provides insight into how payer value frameworks will continue to evolve.

Download the ready-to-present slides and accompanying talking points to share with your team and inform your evidence generation and communication strategies.

Download the slides